Loading…

CeloNova BioSciences signed a three-year group purchasing agreement with HealthTrust for its COBRA PzF NanoCoated Coronary Stent System, effective February 1, 2019.
“We are very pleased to be partnering with HealthTrust to offer a personalized DAPT treatment option to its members.”biospace.com
Summarized from public sources; check the original articles before acting on it.